{
  "cui": "C1328504",
  "cui_name": "Hormone refractory prostate cancer",
  "incidence_per_100k": 4.5,
  "total_cases_per_year": 360000,
  "confidence": 0.7,
  "is_subtype": true,
  "parent_disease": "Prostate Cancer",
  "reasoning": "HRPC/CRPC is a well-documented prostate cancer subtype affecting 10-20% of prostate cancer cases. Global prostate cancer incidence ~60-70 per 100k men; HRPC estimated at 5-8 per 100k men (~4.5 per 100k total population). Data from cancer registries and clinical trials supports this estimate.",
  "data_quality": "moderate",
  "geographic_variation": "high",
  "year_specific": false,
  "data_year": null
}